SCHEMBL7703002

SCHEMBL7703002

COc1ccc(-c2cc(N)n3nc(-c4ccccn4)nc3c2)c(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.47
SYK P43405 1/20 0.46
ATM Q13315 4/20 0.45
CHRNA7 P36544 1/20 0.45
F2 P00734 1/20 0.44
F12 P00748 1/20 0.44
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.42
PKM P14618 2/20 0.42
HPGD P15428 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
TLR9 Q9NR96 2/20 0.42
TLR7 Q9NYK1 1/20 0.42
PIK3CA P42336 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709217 0.89 GRM5 (0.50) ADORA2AATMCHRNA7F2F12
SCHEMBL7431382 0.86 NPC1 (0.52) ADORA2AATMF2F12HSD17B10
SCHEMBL7485182 0.84 ADORA2A (0.49) ADORA2AATMF2F12NPC1
SCHEMBL7483006 0.84 NPC1 (0.53) ADORA2AATMF2F12HSD17B10
SCHEMBL7709212 0.82 ADORA2A (0.49) ADORA2AATMNPC1ALDH1A1KDM4E
SCHEMBL7428533 0.80 ADORA2A (0.60) ADORA2AF2F12NPC1RAB9A
SCHEMBL7709129 0.80 ADORA2A (0.56) ADORA2A
SCHEMBL7709024 0.80 NPC1 (0.41) ADORA2ATSHRHSD17B10NPC1RAB9A
SCHEMBL7711376 0.79 ADORA2A (0.53) ADORA2AF2F12NPC1RAB9A
SCHEMBL7708869 0.78 ADORA2A (0.49) ADORA2ATSHRHSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed